Your browser doesn't support javascript.
loading
Are capecitabine and oxaliplatin (XELOX) suitable treatments for progressing low-grade and high-grade neuroendocrine tumours?
Bajetta, Emilio; Catena, Laura; Procopio, Giuseppe; De Dosso, Sara; Bichisao, Ettore; Ferrari, Leonardo; Martinetti, Antonia; Platania, Marco; Verzoni, Elena; Formisano, Barbara; Bajetta, Roberto.
Affiliation
  • Bajetta E; S.C. Oncologia Medica 2, Istituto Nazionale per lo Studio e la Cura dei Tumori, Via G. Venezian, 1, Milan 20133, Italy. emilio.bajetta@istitutotumori.mi.it
Cancer Chemother Pharmacol ; 59(5): 637-42, 2007 Apr.
Article in En | MEDLINE | ID: mdl-16937105
Subject(s)
Search on Google
Add to My VHL
Print
XML
PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Organoplatinum Compounds / Antineoplastic Combined Chemotherapy Protocols / Neuroendocrine Tumors / Deoxycytidine / Fluorouracil Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Cancer Chemother Pharmacol Year: 2007 Document type: Article Affiliation country: Italy Country of publication: Germany
Search on Google
Add to My VHL
Print
XML
PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Organoplatinum Compounds / Antineoplastic Combined Chemotherapy Protocols / Neuroendocrine Tumors / Deoxycytidine / Fluorouracil Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Cancer Chemother Pharmacol Year: 2007 Document type: Article Affiliation country: Italy Country of publication: Germany